Curtiss-Wright Q3 adjusted diluted EPS rises 16% to $3.94
Bitget2026/11/04 22:40- Curtiss-Wright’s third-quarter 2026 adjusted diluted EPS climbed 16% year-over-year to $3.94.
- Adjusted operating income rose 11% to $189 million, while sales increased 10% to $953 million.
- New orders jumped 15% to $1.1 billion, driven by strong demand across defense markets.
- Full-year 2026 adjusted guidance rose to $15.40–$15.60 for diluted EPS and $3.795 billion–$3.84 billion for sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.
AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Crypto prices
More
